You already brushed your teeth. That's the detail you'd never say out loud, because it makes it sound worse than it is, or exactly as bad as it is. You brushed your teeth, which was supposed to be the ending, and forty minutes later you are standing in the cold light of the open freezer with the spoon already in your hand.

Dinner was fine. You ate a real dinner. You weren't even hungry in the way that word is supposed to mean — no stomach growl, no lightheadedness. It's more like a channel that won't turn off. You thought about the ice cream while you were loading the dishwasher. You thought about it during the show. You negotiated: a square of chocolate instead, a handful of chips instead, and then the negotiation ended the way it usually does.

There was also the bag of chips at your desk at three, grazed without ever deciding to.

And in the morning you will do the accounting, the way you've done it for years. You will decide that the difference between you and the women who don't do this is that they have something you don't. Discipline, or self-respect, or whatever you're calling it this month.

That accounting is the thing I want to interrupt, because it isn't what the research shows at all.

A third of women with PCOS have disordered eating patterns on formal screening, and the odds of an abnormal eating-disorder score are roughly three times higher than in women without it. Not because three times as many women with PCOS lack character. Because something upstream of character is different, and it has been measured.

What you were actually up against

Appetite is not a verdict on who you are. It's a signal, and like every other signal in this condition it arrives from somewhere you didn't choose.

Here is the part that reframes years of self-blame: you are not failing to hear the signal that tells you to stop. In women with PCOS, that signal is quieter — and researchers have watched it be quieter, in blood draws, after identical meals.

It isn't permanent either. The signals that got turned down can be turned back up, and two of the drugs that do it are ones you can ask about by name at an ordinary appointment.

But first the mechanism, because the mechanism is what makes any of this believable.

Two ends of the same curve

The background is the same machinery I wrote about in the post on abdominal weight gain: cells respond sluggishly to insulin, the pancreas compensates by making more of it, and chronically high insulin raises ovarian androgen production while suppressing the SHBG that would otherwise keep testosterone bound. That's the engine. Here is what it does to hunger specifically.

After a meal, your body is supposed to run a shutdown sequence. Ghrelin — the hormone that says find food — drops. CCK rises from the gut and tells the brain the meal happened. Leptin, from your fat tissue, reports that reserves are adequate.

In PCOS, all three readings are off. Women with PCOS show a smaller drop in post-meal ghrelin than weight-matched women without it — the find food signal doesn't switch off as far. Post-meal CCK is blunted, and the degree of blunting tracks with testosterone levels. And leptin is typically high but the brain responds poorly to it, so the reserves report arrives and nothing reads it.

Three separate "you can stop now" messages, all sent quietly. You were not refusing to hear them.

Now the afternoon. You ate lunch, something with fast carbohydrate in it, and an insulin-resistant pancreas answered with a large amount of insulin. Insulin stays elevated in the circulation after your stomach has already emptied, and blood glucose falls further than it should. In one line of research, a third of women with PCOS dropped into reactive hypoglycemia after simple carbohydrate — and among lean women with PCOS, one study found the rate was about half. Peak glucose ran high at one hour; the nadir hours later ran near 61 mg/dL.

That nadir is the two o'clock feeling. Weakness, shakiness, sweating, palpitations, the particular desperation of needing to put your head down, and hunger that arrives out of proportion to the meal you just ate.

Two more findings turn this from unpleasant into important. First, in that same work the hypoglycemic symptoms coincided with a surge of cortisol and adrenal androgens — so the crash isn't only miserable, it's pouring fuel on the hormonal fire. Second, after simple carbohydrate, ghrelin started climbing again about two hours in, while after protein it stayed suppressed across five hours. Not a diet instruction. A fact about the shape of the curve.

So the three o'clock chips and the nine-forty freezer aren't two failures. They're the downslope of the same curve, and by evening your body has spent the whole day being told to find food.

Willpower does not change a signal. It can override one, for a while, at a cost — and that override is precisely what you've been doing for years and calling the bare minimum.

What to ask for

Ask for measurements first. A HbA1c or, better, an oral glucose tolerance test, which the 2023 international guideline names as the first-choice test for glucose status in PCOS. Describe the post-meal crash specifically, including the timing — two hours, three hours — because the timing is the clinical clue and it's the detail most likely to go unmentioned.

Then the two drugs.

Metformin lowers the glucose your liver releases and improves how your tissues respond to insulin, which flattens the spike that the crash follows. Its effect on appetite itself is real but modest, and the mechanism is genuinely unsettled — there's good evidence it raises GDF15, a hormone acting on appetite circuits in the hindbrain, and other work arguing that pathway isn't required. It's off-label for PCOS, meaning approved for type 2 diabetes and used here on guideline recommendation rather than FDA indication, which is ordinary rather than alarming. Cost of entry: GI upset, worst early and worst on immediate-release, often better on extended-release, with B12 worth monitoring long term.

GLP-1 receptor agonists act directly on the system this post is about. They slow gastric emptying and act on GLP-1 receptors in the hypothalamus, and in trials they reduce hunger and food preoccupation and improve the sense of fullness. Researchers now study this under the name food noise — intrusive, unwanted thoughts about food — with validated questionnaires, which means the thing you couldn't describe at an appointment has a literature and a measuring instrument.

The honest limits: in PCOS specifically, pooled trials show modest weight reduction and improved insulin resistance but no demonstrated effect on testosterone, and the reproductive data are thin. Side effects are nausea, vomiting and constipation. There are insurance fights, muscle loss without adequate protein and resistance training, and weight regain for many people who stop. They are not for use in pregnancy and need a washout before trying to conceive.

Bring the sentence:

I get an intense crash about two hours after eating, and cravings at night that I can't override. That pattern makes me think insulin resistance. Can we check a HbA1c or a glucose tolerance test, and talk about whether metformin or a GLP-1 makes sense for me?

Two doors, and then it's yours

The first door is your PCP, OB-GYN, or endocrinologist. Bring the timings. Ask for the labs.

One thing to hold onto while you go. Given how often disordered eating travels with this condition, there's a real chance you'll be offered a food diary and a calorie target by someone who never checks a glucose curve. If you've been bingeing, that deserves actual care — not a stricter plan handed to someone whose satiety signaling is already impaired. A clinician who treats this as a discipline problem has told you about their training, not about you.

The second door is telehealth built for this. Allara Health is a virtual practice for PCOS and women's hormonal and metabolic health that pairs clinicians with registered dietitians and works with many major insurance plans, though state availability varies. Sesame is a direct-pay marketplace where you book a named clinician at a listed price without insurance or a referral, useful if you're uninsured or facing a long wait.

I want to be clear that I have no financial relationship with either of these. I'm not an affiliate and I don't get paid if you book. I mention them because "find a doctor who actually knows PCOS" is useless advice without somewhere to start.

PCOS is managed, not cured, and I won't promise you a number or a date. But the quiet at nine-forty that you've been trying to produce with resolve is something many women only got when the signal changed, and the signal is treatable. You have been doing this on hard mode, without being told it was hard mode, and doing it anyway. That was never a character defect. It was an untreated one.

This is my experience and my reading of the research, not medical advice. Nothing here should replace a conversation with a clinician who knows your history.

Sources

1. Food Cravings and Obesity in Women with Polycystic Ovary Syndrome: Pathophysiological and Therapeutic Considerations — Stefanaki et al., Nutrients, 2024
2. Reactive Hypoglycemia: A Trigger for Nutrient-Induced Endocrine and Metabolic Responses in Polycystic Ovary Syndrome — Karakas, Journal of Clinical Medicine, 2023
3. Increased odds of disordered eating in polycystic ovary syndrome: a systematic review and meta-analysis — Lee et al., Eating and Weight Disorders, 2019
4. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of PCOS — Teede et al., Journal of Clinical Endocrinology and Metabolism, 2023
5. Metformin-induced increases in GDF15 are important for suppressing appetite and promoting weight loss — Coll et al., Nature Metabolism, 2020
6. Food noise: definition, measurement, and future research directions — Nutrition & Diabetes, 2025

They still fit everywhere except one place.

That was always the strange part, the part you never quite said out loud. Your arms are the same. Your legs are the same. The boots still zip, the sleeves still button at the wrist, your rings still turn on your fingers the way they always have. It is the waistband. Only ever the waistband.

So you did the reasonable thing. You bought the next size, and when that one stopped closing you bought the size after it, and somewhere in there you started quietly choosing clothes that don't have a waistband at all. Dresses. Anything that ties. The jeans went to the back of the closet instead of the donation bag, because putting them in the bag would have meant admitting something.

You hadn't changed how you ate. If anything you were more careful than you'd been at thirty, because by then you'd been careful for a decade. And everyone you asked said the same thing. Metabolism slows down. It's perimenopause. This is what happens to women.

So you stopped asking. Not in a single dramatic moment — you just filed it under aging, the way you file anything that has stopped being a question.

When researchers interviewed twenty-nine peri- and postmenopausal women with PCOS in 2025, most described exactly this — sixty-nine percent reported weight gain that worsened with age, and about a third had arrived somewhere past hoping. One put it in a sentence: You have to just accept that it will never be better.

If you've thought some version of that, you're not being dramatic and you're not being weak. You're being reasonable with the information you were given.

The information was incomplete.

What the pattern was telling you

Here is what nobody said at any of those appointments.

Where your body puts weight is information. Not about your discipline. About your endocrinology.

Weight that arrives everywhere at once — arms, legs, face, middle — is a different physiological event from weight that goes almost entirely to your abdomen while your limbs stay exactly as they were. The first is a story about calories. The second is a story about hormones, and it is specific enough to be measured on a blood test.

You noticed this pattern years ago. You just weren't told it meant anything, so you read it as vanity instead of as the most useful clue in the picture.

It also isn't permanent. Hold onto that through the next part, because the mechanism is what earns it.

Why the fat went there and not somewhere else

Insulin resistance means your cells respond sluggishly to insulin, so your pancreas compensates by making more of it. That chronically elevated insulin does two things at once: it signals the theca cells in your ovaries to produce more androgens, and it suppresses your liver's production of SHBG, the protein that binds testosterone and keeps it inactive. More testosterone made, less of it bound. Free testosterone rises.

Androgens don't just affect skin and hair. They change the address fat is delivered to.

A study at UCLA funded by the NIH looked at normal-weight women with PCOS and found they stored fat differently — more fat packed around the internal organs of the abdomen, and less subcutaneous fat beneath the skin of the abdomen, buttocks and thighs, compared with women of the same weight without PCOS. The women in the study whose androgen levels were normal didn't show the abdominal pattern at all.

Read that again with your own closet in mind. Your arms and legs didn't stay the same because you got lucky above the waist. They stayed the same because the fat was being routed past them.

And the destination matters more than the size of the jeans. Subcutaneous fat — hips, thighs, the fat you can pinch — is relatively quiet storage. Visceral fat, the fat around your organs, drains straight into the portal vein and empties into your liver, delivering a constant supply of free fatty acids and inflammatory signals. The liver responds by producing more glucose and becoming less sensitive to insulin, regardless of your BMI. Higher insulin then drives more visceral storage.

It's a loop, and it tightens on itself. The belly isn't the result of the problem. It's participating in it.

Which is why this is a health question and not a clothing question. Women with PCOS carry roughly four times the odds of type 2 diabetes as women without it. In a meta-analysis of more than a million women, PCOS was associated with elevated odds of ischemic heart disease, and the 2023 international guideline now recommends cardiovascular risk assessment in PCOS regardless of age or BMI. A rising A1c is not a number about your size. It's your pancreas filing a report.

Willpower does not change a signal. Every behavior you can control sits downstream of the hormone. You can do everything correctly and barely move the outcome, because the instruction your body is receiving never changed. The effort wasn't failing. It was working, into a headwind nobody told you was there.

The part where perimenopause is also true

I'm not going to tell you your doctor invented the perimenopause explanation. It's real, and it does this.

As estrogen declines, fat genuinely redistributes from the hips and thighs toward the abdomen, and that shift happens independently of chronological aging. Across the transition, visceral fat climbs from roughly five to eight percent of total body fat to fifteen or twenty percent.

So the person who told you it was perimenopause wasn't wrong. They stopped one sentence too early.

Two processes are pushing in the same direction, in the same place, at the same time in your life. That's a reason to look harder, not a reason to stop looking — and it's exactly why this gets missed. The explanation that requires nothing of anyone happens to be partly true.

What to ask for

Ask for numbers before you ask for a prescription. A HbA1c or, better, an oral glucose tolerance test — the 2023 guideline names the OGTT first choice and A1c as less accurate but reasonable. A lipid panel. Blood pressure. Thyroid function too, and if the central pattern came on fast, ask what else is being ruled out, including Cushing's, and whether a medication you take could be contributing.

Then the two drugs worth asking about by name.

Metformin lowers the glucose your liver produces and improves how your tissues respond to insulin, and the international guideline recommends it for metabolic features in PCOS. It isn't FDA-approved for PCOS specifically — it's approved for type 2 diabetes and used off-label here, which is legal, decades old, and guideline-backed rather than fringe. The honest cost: GI upset for a lot of women, especially early and especially on the immediate-release form; extended-release is often tolerated better; long-term use warrants B12 monitoring.

GLP-1 receptor agonists slow gastric emptying, act on appetite signaling, and improve insulin sensitivity. Here the evidence needs care. Pooled trials in PCOS show modest short-term weight reduction and improved insulin resistance, but meta-analysis has not shown a significant effect on total testosterone, and the reproductive data stay thin. Real trade-offs: nausea and constipation, insurance fights and cash prices, muscle loss without enough protein and resistance training, and regain for many people who stop. They aren't for use in pregnancy and need a washout before trying to conceive.

Bring the sentence with you:

My weight gain has been almost entirely in my middle — my arms and legs haven't changed. That pattern makes me think insulin resistance. Can we check a HbA1c or a glucose tolerance test and a lipid panel, and talk about whether metformin or a GLP-1 makes sense for me?

Give it months, not weeks. And notice what actually improves, because it usually isn't the scale first — it's the A1c, the triglycerides, the afternoon crash, the cycle. Those are the wins.

Two doors, and then it's yours

The first door is your PCP, OB-GYN, or endocrinologist. Go, bring the sentence, ask for the labs in writing.

Know before you go that this gets missed constantly. PCOS affects roughly one in ten women and is still routinely handled with a birth control prescription and no metabolic workup at all. In that 2025 study, one woman had been through two endocrinologists, an OB-GYN and her family doctor, and said plainly that nobody was listening. If your appointment goes that way, you have learned something about that clinician's training, not about whether your symptoms are real. Ask for the labs anyway, or ask someone else.

The second door is telehealth built for this. Allara Health is a virtual practice for PCOS and women's hormonal and metabolic health that pairs clinicians with registered dietitians and works with many major insurance plans, though availability varies by state. Sesame is a direct-pay marketplace where you book a named clinician at a listed cash price without insurance or a referral — useful if you're uninsured, between plans, or facing a six-month wait for an endocrinologist.

I want to be clear that I have no financial relationship with either of these. I'm not an affiliate and I don't get paid if you book. I mention them because "find a doctor who actually knows PCOS" is useless advice without somewhere to start.

PCOS is managed, not cured, and I'm not going to promise you a number or a timeline. But the thing you were told to accept as your forties is a measurable signal with treatments that move it, and women with your exact labs have moved them. You were never required to make peace with this. You were only ever required to get it looked at.

The jeans can stay in the closet. That was never the point.

This is my experience and my reading of the research, not medical advice. Nothing here should replace a conversation with a clinician who knows your history.

Sources

1. I feel like it gets worse as I get older: perspectives of peri-postmenopausal women with PCOS — Wright, Corbett, Dawson & Burts, Frontiers in Global Women's Health, 2025
2. Fat-cell storage altered in women with infertility disorder — NICHD/NIH, on Dumesic et al., Journal of Clinical Endocrinology and Metabolism, 2016
3. The pathophysiology of visceral adipose tissues in cardiometabolic diseases — Biochemical Pharmacology, 2024
4. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of PCOS — Teede et al., Journal of Clinical Endocrinology and Metabolism, 2023
5. 2023 International Evidence-Based PCOS Guideline Update: meta-analysis on elevated clinical cardiovascular disease in PCOS — Journal of the American Heart Association, 2024
6. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in PCOS — Legro et al., Journal of Clinical Endocrinology and Metabolism, 1999
7. The impact of the menopausal transition on body composition and abdominal fat redistribution — 2025
8. GLP-1 receptor agonist treatment in women with polycystic ovary syndrome: a systematic review and meta-analysis — European Journal of Endocrinology, 2026